GGrantIndex
Sort

8,912 grants matching sars cov 2

Mutational Analysis of Tradeoffs between Receptor Affinity and Antibody Escape for SARS-CoV-2 Variants of Concern

$185,721
Peter M Tessier · University Of Michigan At Ann Arbor · R21 · FY2023 · AI

Detection and Automatic Privacy-Protected Contact Tracing System Designed for COVID-19

$185,706
Lu Peng · Louisiana State Univ A&M Col Baton Rouge · U01 · FY2022 · AA

Curating a Knowledge Base for Individuals with Coinfection of HIV and SARS-CoV-2: EHR-based Data Mining

$185,676
Xiaoming Li · University Of South Carolina At Columbia · R21 · FY2023 · AI

Surveillance of wildlife and livestock for novel and emerging coronaviruses

$185,625
Eric A Nelson · South Dakota State University · R21 · FY2022 · AI

Translational Regulation of SARS-CoV-2 in response to viral S protein-induced signaling

$185,625
Barsanjit Mazumder · Cleveland State University · R21 · FY2024 · AI

The Impact of the COVID19 Pandemic on the Hispanic/Latinx Birth Outcome Advantage

$185,603
Reanne Frank · Ohio State University · R03 · FY2024 · HD

Multivariate spatiotemporal models to quantify disparities in COVID-19 health outcomes

$185,516
Brian Neelon · Medical University Of South Carolina · R21 · FY2023 · MD

Project 4: Inflammatory monocyte-macrophages in age-related susceptibility to SARS-CoV-2 infection

$185,333
Rudragouda Channappanavar · Oklahoma State University Stillwater · P20 · FY2022 · GM

Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization - Clinical Core

$185,244
Margaret Juliana McElrath · Seattle Children'S Hospital · U19 · FY2023 · AI

Sequencing Core

$185,178
Gregory Seumois · La Jolla Institute For Immunology · U19 · FY2022 · AI

Developing a resiliency intervention to support healthcare workers engaged in the provision of HIV care

$185,151
Christina Psaros · Massachusetts General Hospital · R34 · FY2022 · MH

Patterns of immune response in COVID-19 patients

$185,073
Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Newborn cohorts to discover and validate biomarkers of neonatal vaccine immunogenicity

$184,957
Ofer Levy · Boston Children'S Hospital · U19 · FY2020 · AI

IMmunoPhenotyping Assessment of a Covid-19 Cohort (IMPACC): Clinical Site

$184,957
Ofer Levy · Boston Children'S Hospital · U19 · FY2020 · AI

Biological role of SARS-CoV2 Superantigenic structure in hyperinflammatory syndromes

$184,894
Moshe Arditi · Cedars-Sinai Medical Center · R01 · FY2020 · AI

Role of Pellino-1 in COVID-19 diseases

$184,865
Tian Wang · University Of Texas Med Br Galveston · R21 · FY2020 · AI

Investigating linkages between arsenic exposure, diabetes, and COVID-19 infections and risks on the Navajo Nation

$184,568
Stephanie Russo Carroll · University Of Arizona · R21 · FY2021 · ES

Myeloid cell TRAF6 signaling in SARS-CoV-2-induced dysregulated lung immunity

$184,519
Rudragouda Channappanavar · Oklahoma State University Stillwater · R21 · FY2025 · AI

A Multi-site Investigation of Social Determinants of Health and SARS-CoV-2 Testing and Vaccination Outcomes among Diverse US Latinx Adults

$184,375
Stephanie De Anda · University Of Oregon · R21 · FY2023 · MD

Transgenic Mouse Models for Pathogenesis and Therapy

$184,315
Tehsheng Chan · University Of Texas Med Br Galveston · R21 · FY2006 · AI

Extracellular vesicles encapsulating CRISPR machinery for treatment of SARS-CoV-2 infection

$184,222
Houjian Cai · University Of Georgia · R21 · FY2024 · AI

CEIRR: SARS-CoV-2 Research Activities

$184,160
Anice Lowen · Emory University · N01 · FY2023 · AI

Dissecting mechanisms of antibody-Fc interactions that shape innate immune antiviral responses.

$183,960
Bronwyn Mei Gunn · Washington State University · R21 · FY2024 · AI

The Development of Reversible Covalent PROTAC Technology as a New Anti-COVID-19 Strategy

$183,769
Shiqing Xu · Texas A&M University · R21 · FY2022 · AI

Interaction of Biopsychosocial Stress, Alcohol Misuse, and Neurobehavioral Sequelae of COVID-19

$183,750
Tekeda F. Ferguson · Lsu Health Sciences Center · R21 · FY2023 · AA